Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma.

Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma.

Item
http://www.wikidata.org/entity/Q38946509
A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesisTankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells.Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells.Differential regulation of AKT1 contributes to survival and proliferation in hepatocellular carcinoma cells by mediating Notch1 expression.Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells.
P2860

Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma.

Item
http://www.wikidata.org/entity/Q38946509
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Vertical Targeting of AKT and ...... c in Hepatocellular Carcinoma.
@en
type
label
Vertical Targeting of AKT and ...... c in Hepatocellular Carcinoma.
@en
prefLabel
Vertical Targeting of AKT and ...... c in Hepatocellular Carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Vertical Targeting of AKT and ...... c in Hepatocellular Carcinoma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932